Literature DB >> 19585900

Does sex make a difference in survival of patients undergoing resection for early stage non-small cell lung cancer (NSCLC)?

Steven J Jubelirer1, Nicole L Varela, Christine A Welch, Mary K Emmett.   

Abstract

OBJECTIVE: To determine if sex associated differences exist in presentation and survival of patients undergoing resection for early stage nonsmall cell lung cancer (NSCLC). PATIENTS AND METHODS: Retrospective review of 2207 patients with Surveillance, Epidemiology, and End Results (SEER) Summary Stage I, II or III (local or regional disease) patients eligible for surgery, nonsmall cell lung cancer diagnosed and treated in WV between 1993 and 2000, which underwent surgery as a first course of treatment. Data set obtained from the West Virginia Cancer Registry.
RESULTS: 1332 male cases and 875 female cases were reviewed. No statistically significant difference was found with mean age of diagnosis (men 66.5 years; women 67.2 years). A greater proportion of women had adenocarcinoma (p < 0.0001), lower grade (p = 0.002), and lower SEER summary stage (p = 0.009). There was no difference in laterality of tumor, 30-day post surgery survival or surgical procedure between men and women. Regression analysis showed a higher hazard ratio was associated with a increasing stage, grade, and those > or =65 years of age while lower hazard ratio was associated with adenocarcinoma.
CONCLUSIONS: This study found that stage, grade, age, and histology, but not sex was the significant prognostic indicators of death in five years.

Entities:  

Mesh:

Year:  2009        PMID: 19585900

Source DB:  PubMed          Journal:  W V Med J        ISSN: 0043-3284


  5 in total

Review 1.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

Review 2.  [Gender-associated differences of lung cancer and mechanism].

Authors:  Xin Xing; Yongde Liao; Hexiao Tang; Guang Chen; Sheng Ju; Liangkun You
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-07

3.  Exploring the survival prognosis of lung adenocarcinoma based on the cancer genome atlas database using artificial neural network.

Authors:  Na Jiang; Xianrong Xu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Somatic mutations combined with clinical features can predict the postoperative prognosis of stage IIIA lung adenocarcinoma.

Authors:  Jiuzhen Li; Xuefeng Lin; Xin Li; Weiran Zhang; Daqiang Sun
Journal:  Ann Transl Med       Date:  2022-02

5.  Time-varying effect of sex on prognosis of lung adenocarcinoma surgical patients in China.

Authors:  Zezhou Wang; Miao Mo; Changming Zhou; Xiaoshuang Feng; Jie Shen; Ting Ye; Yang Zhang; Hong Hu; Haiquan Chen; Ying Zheng
Journal:  Thorac Cancer       Date:  2021-05-03       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.